We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+11.02%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$198M
AUM Growth
+$37.9M
Cap. Flow
+$42.3M
Cap. Flow %
21.36%
Top 10 Hldgs %
27.74%
Holding
86
New
20
Increased
29
Reduced
15
Closed
16

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$3.48M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$2.5M
3
CFN
CAREFUSION CORPORATION
CFN
+$2.48M
4
CAH icon
Cardinal Health
CAH
+$2.38M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2.37M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$3.35M
2
AMGN icon
Amgen
AMGN
+$3.08M
3
CVS icon
CVS Health
CVS
+$2.6M
4
BSX icon
Boston Scientific
BSX
+$2.39M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.1M

Sector Composition

Rank Sector Weight
1 Healthcare 88.23%
2 Financials 0%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
51
Illumina
ILMN
$29B
$1.61M 0.81%
9,252
-1,028
-10% -$153K
MD icon
52
Pediatrix Medical
MD
$2.13B
$1.52M 0.77%
+26,100
New +$1.54M
IPXL
53
DELISTED
Impax Laboratories, Inc.
IPXL
$1.5M 0.76%
+50,000
New +$1.35M
PRGO icon
54
Perrigo
PRGO
$1.76B
$1.46M 0.74%
+10,000
New +$1.42M
NXTM
55
DELISTED
NxStage Medical Inc.
NXTM
$1.44M 0.73%
100,000
– –
CBST
56
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$1.4M 0.7%
+20,000
New +$1.36M
BDX icon
57
Becton Dickinson
BDX
$49.1B
$1.37M 0.69%
+11,864
New +$1.35M
NPSP
58
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$1.32M 0.67%
+40,000
New +$1.16M
CCRN
59
DELISTED
Cross Country Healthcare
CCRN
$1.3M 0.66%
200,000
+50,000
+33% +$331K
QGENF
60
DELISTED
QIAGEN NV
QGENF
$1.21M 0.61%
+49,451
New +$1.21M
GMED icon
61
Globus Medical
GMED
$11.5B
$1.19M 0.6%
49,538
– –
HTWR
62
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$1.15M 0.58%
13,000
– –
PODD icon
63
Insulet
PODD
$9.96B
$992K 0.5%
25,000
– –
ITMN
64
DELISTED
INTERMUNE INC
ITMN
$883K 0.45%
+20,000
New +$736K
VIRX
65
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$391K 0.2%
286
-14
-5% -$16.2K
ACHC icon
66
Acadia Healthcare
ACHC
$2.95B
$278K 0.14%
6,108
-18,892
-76% -$830K
CYH icon
67
CALL
Community Health Systems
CYH
$415M
$205K 0.1%
+60,500
New +$2.01M
HCA icon
68
CALL
HCA Healthcare
HCA
$89.3B
$187K 0.09%
+50,500
New +$2.66M
DIA icon
69
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.5B
$130K 0.07%
+100,000
New +$16.6M
VRTX icon
70
PUT
Vertex Pharmaceuticals
VRTX
$134B
$2K ﹤0.01%
+20,000
New +$1.4M
AMGN icon
71
Amgen
AMGN
$224B
– –
-25,000
Closed -$3.08M
BRKR icon
72
Bruker
BRKR
$8.65B
– –
-88,400
Closed -$2.02M
BSX icon
73
Boston Scientific
BSX
$73.5B
– –
-176,950
Closed -$2.39M
CVS icon
74
CVS Health
CVS
$120B
– –
-34,780
Closed -$2.6M
GILD icon
75
Gilead Sciences
GILD
$167B
– –
-25,000
Closed -$1.77M
1 2
3
4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q2 2014 Portfolio in Review

As of Q2 2014, Sivik Global Healthcare held 86 positions worth $198M, up 24% from $160M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Sivik Global Healthcare deployed $42.3M of net new capital in Q2 2014, opening 20 new positions and adding to 29 existing holdings. Its largest new stake was Shire pic: 20,000 shares worth $4.71M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 89% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Celgene Corp, an estimated $1.84M trimmed.

  • Sivik Global Healthcare's largest Q2 2014 buy was Shire pic: 20,000 shares worth $4.71M.
  • Sivik Global Healthcare added most to Cardinal Health in Q2 2014, an estimated $2.38M increase.
  • Sivik Global Healthcare's biggest Q2 2014 reduction was Celgene Corp, cutting an estimated $1.84M.
  • Sivik Global Healthcare fully exited Aetna Inc in Q2 2014, selling an estimated $3.35M.
  • Sivik Global Healthcare's ten largest holdings make up 28% of its $198M portfolio in Q2 2014.
  • Sivik Global Healthcare opened 20 new positions and closed 16 in Q2 2014.
  • Sivik Global Healthcare's portfolio value rose 24% quarter-over-quarter to $198M.

Based on Sivik Global Healthcare's 13F filing for Q2 2014, filed 3 Jul 2014.